CLINICAL_TRIALS
trial_result
· 2016-05-20
Clinical Trial Update: Study of Efficacy and Safety of LDE225 in Adult Patients With Relapsed/Refractory Acute Leukemia [Phase 2]
Summary
Phase 2 study evaluating the efficacy and safety of LDE225 (sonidegib) in adults with relapsed/refractory acute leukemia completed; results were posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Acute Leukemias | Phase 2 | Status: COMPLETED | Results posted: 2016-05-20